Publications
Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.
Proc Natl Acad Sci U S A 2012 May 14;
PMID: 22586108
Walsh DJ, Noble GP, Piro JR, Supattapone S
Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein.
Prep Biochem Biotechnol 2012; 42(1):77-86
PMID: 22239709
Miller MB, Geoghegan JC, Supattapone S
Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
PLoS Pathog 2011 Jul; 7(7):e1002128
PMID: 21779169
Piro JR, Wang F, Walsh DJ, Rees JR, Ma J, Supattapone S
Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
Biochemistry 2011 Aug 23; 50(33):7111-6
PMID: 21776987
Piro JR, Supattapone S
Photodegradation illuminates the role of polyanions in prion infectivity.
Prion 2011 Apr-Jun; 5(2):49-51
PMID: 21646861
Piro JR, Harris BT, Supattapone S
In situ photodegradation of incorporated polyanion does not alter prion infectivity.
PLoS Pathog 2011 Feb 3; 7(2):e1002001
PMID: 21304885
Miller MB, Supattapone S
Superparamagnetic nanoparticle capture of prions for amplification.
J Virol 2011 Mar; 85(6):2813-7
PMID: 21228242
Deleault NR, Kascsak R, Geoghegan JC, Supattapone S
Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro.
Biochemistry 2010 May 11; 49(18):3928-34
PMID: 20377181
Supattapone S
Biochemistry. What makes a prion infectious?
Science 2010 Feb 26; 327(5969):1091-2
PMID: 20185716
Supattapone S, Piro JR, Rees JR
Complex polyamines: unique prion disaggregating compounds.
CNS Neurol Disord Drug Targets 2009 Nov; 8(5):323-8
PMID: 19702574
View all publications on PubMed